A placebo-controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans.

Arout, Caroline A; Haney, Margaret; Herrmann, Evan S; Bedi, Gillinder; Cooper, Ziva D

Arout, Caroline A; Haney, Margaret; Herrmann, Evan S; Bedi, Gillinder; Cooper, Ziva D.

Afiliação

Arout CA; Division on Substance Use Disorders, New York Psychiatric Institute and Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
Haney M; Division on Substance Use Disorders, New York Psychiatric Institute and Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
Herrmann ES; Division of Therapeutics and Medical Consequences, National Institute on Drug Abuse, USA.
Bedi G; Centre for Youth Mental Health, The University of Melbourne and Substance Use Research Group, Melbourne, Australia.
Cooper ZD; University of California, Los Angeles Cannabis Research Initiative, Jane & Terry Semel Institute for Neuroscience & Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Los Angeles, CA, USA.

Br J Clin Pharmacol ; 88(1): 347-355, 2022 01.

Article em En | MEDLINE | ID: mdl-34223660

Assuntos

Analgesia; Canabidiol; Analgésicos/efeitos adversos; Canabidiol/farmacologia; Método Duplo-Cego; Feminino; Humanos; Masculino; Dor/induzido quimicamente; Dor/tratamento farmacológico; Medição da Dor

Palavras-chave

abuse liability; analgesia; cannabidiol; cannabinoids; pain

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Canabidiol / Analgesia Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google